Skip to main content
. 2000 Jun 6;97(13):7482–7487. doi: 10.1073/pnas.120474397

Figure 3.

Figure 3

Quantification of the area of 50-μm brain sections occupied by β-galactosidase, ED1, CD8, and MHC I immunoreactivity. Error bars show the SEM value from the three animals in each experimental group. At 60 days post-intradermal injection, there was no β-galactosidase immunoreactivity remaining in any of the animals injected intracranially with RAd35 and peripherally with RAdHPRT.